☰

Ila Joshi, Ph.D. - Publications

Affiliations: 
2008 Molecular & Cellular Biology University of Massachusetts, Amherst, Amherst, MA 
Area:
Molecular Biology, Immunology
Tree Info Grants Similar researchers PubMed Report error

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Hu Y, Zhang Z, Kashiwagi M, Yoshida T, Joshi I, Jena N, Somasundaram R, Emmanuel AO, Sigvardsson M, Fitamant J, El-Bardeesy N, Gounari F, Van Etten RA, Georgopoulos K. Superenhancer reprogramming drives a B-cell-epithelial transition and high-risk leukemia. Genes & Development. 30: 1971-90. PMID 27664237 DOI: 10.1101/Gad.283762.116  0.429
2016 Etten RV, Hu Y, Zhang Z, Yoshida T, Jena N, Kashiwagi M, Joshi I, El-Bardeesy N, Somasundaram R, Sigvardsson M, Liu Z, Tata P, Korber S, Raufi A, Krause D, et al. Central role for ikaros in pre-B cell differentiation and pathogenesis of high-risk B-cell acute lymphoblastic leukemia Experimental Hematology. 44. DOI: 10.1016/J.Exphem.2016.06.024  0.349
2015 Bakshi R, Zhang H, Logan R, Joshi I, Xu Y, Chen X, Schwarzschild MA. Neuroprotective effects of urate are mediated by augmenting astrocytic glutathione synthesis and release. Neurobiology of Disease. PMID 26341543 DOI: 10.1016/J.Nbd.2015.08.022  0.305
2015 Jena N, Joshi I, Yoshida T, Zhang Z, Liu Z, Tata P, Shapiro IM, Pachter JA, Weaver DT, Georgopoulos K, Etten RAV. Abstract 4202: Targeting focal adhesion kinase is a novel approach to therapy of high-risk, Ikaros-mutant acute B-cell lymphoblastic leukemia Cancer Research. 75: 4202-4202. DOI: 10.1158/1538-7445.Am2015-4202  0.385
2014 Joshi I, Yoshida T, Jena N, Qi X, Zhang J, Van Etten RA, Georgopoulos K. Loss of Ikaros DNA-binding function confers integrin-dependent survival on pre-B cells and progression to acute lymphoblastic leukemia. Nature Immunology. 15: 294-304. PMID 24509510 DOI: 10.1038/Ni.2821  0.378
2014 Joshi I, Jena N, Yoshida T, Paraskevopoulou L, Zhang Z, Liu Z, Korber S, Krause DS, Shapiro IM, Weaver DT, Pachter JA, Paietta EM, Van Etten RA, Georgopoulos K. Focal Adhesion Kinase Inhibitors Reverse the Stromal Adhesion Phenotype of Ikaros-Mutant B-ALL, Induce Apopotosis, and Synergize with ABL1 Tyrosine Kinase Inhibitors: A New Paradigm for Pathogenesis and Therapy of High-Risk B-ALL Blood. 124: 285-285. DOI: 10.1182/Blood.V124.21.285.285  0.387
2013 Jena N, Joshi I, Yoshida T, Qi X, Zhang J, Georgopoulos K, Etten RAV. Ikaros Mutation Confers Integrin-Dependent Survival Of Pre-B Cells and Progression To Acute Lymphoblastic Leukemia Blood. 122: 1259-1259. DOI: 10.1182/Blood.V122.21.1259.1259  0.395
2009 Joshi I, Minter LM, Telfer J, Demarest RM, Capobianco AJ, Aster JC, Sicinski P, Fauq A, Golde TE, Osborne BA. Notch signaling mediates G1/S cell-cycle progression in T cells via cyclin D3 and its dependent kinases. Blood. 113: 1689-98. PMID 19001083 DOI: 10.1182/Blood-2008-03-147967  0.691
2007 Izadi H, Motameni AT, Bates TC, Olivera ER, Villar-Suarez V, Joshi I, Garg R, Osborne BA, Davis RJ, Rincón M, Anguita J. c-Jun N-terminal kinase 1 is required for Toll-like receptor 1 gene expression in macrophages. Infection and Immunity. 75: 5027-34. PMID 17664270 DOI: 10.1128/Iai.00492-07  0.557
Show low-probability matches.